Souhaitez-vous accéder aux communiqués récents ?

SALT LAKE CITY, March 21, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, and Access Health®, an educational program...

SALT LAKE CITY, March 18, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present two important...

WASHINGTON, March 15, 2016 (GLOBE NEWSWIRE) -- Addressing the social determinants of health (SDOH) is well recognized as a paramount issue in the health of communities. Academic health centers, with...

SALT LAKE CITY, March 15, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced the results from the second...

MONTREAL, March 11, 2016 (GLOBE NEWSWIRE) -- This Sunday morning at two a.m., time will move forward by 1 hour to honor the annual daylight savings time tradition that signals the beginning of Spring...

INDIANAPOLIS, IN--(Marketwired - March 09, 2016) - Becknell Industrial announced today financial results for the year ending December 31, 2015. "Becknell was pleased to celebrate its 25th ...

SILVER SPRING, Md., March 9, 2016 (GLOBE NEWSWIRE) -- Given the high stress levels, extended periods of screen time and regular social outings many Americans experience day-to-day in environments...

VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 09, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on...

MADISON, Wis., March 8, 2016 (GLOBE NEWSWIRE) -- A few years ago, a global team of scientists parlayed decades of research into the discovery of the Higgs boson, a subatomic particle considered a...

VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 08, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on...